In September, the US Food and Drug Administration (FDA) proposed safety labeling changes for extended-release and long-acting (ER/LA) opioid analgesics intended to treat pain.
In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available...